Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Maria Sanjurjo"'
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-De-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Ana Herranz-Alonso, Maria Sanjurjo
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 3, p e31016 (2022)
BackgroundImmune-mediated inflammatory diseases (IMIDs) are systemic conditions associated with a high social and health impact. New treatments have changed the prognosis of IMIDs and have increased patient autonomy in disease management. Mobile apps
Externí odkaz:
https://doaj.org/article/48ffc37596eb4d10bcd5ff68ad6a240c
Autor:
María Belen Marzal-Alfaro, Vicente Escudero-Vilaplana, Jose Luis Revuelta-Herrero, Roberto Collado-Borrell, Ana Herranz-Alonso, Maria Sanjurjo-Saez
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe use process for chimeric antigen receptor T (CAR-T) cell drugs is complex and has been associated with a number of potentially severe complications, which requires management by a multidisciplinary team. Pharmacists are a key element in th
Externí odkaz:
https://doaj.org/article/e5a63c2b25e74892b585ad18dcfff5dd
Autor:
González, Carmen Guadalupe Rodríguez, Vega, Esther Chamorro de, Martínez, Sofía De la Villa, Minero, Maricela Valerio, Urbón, José María Gutiérrez, Manzorro, Álvaro Giménez, Martínez, Edurne Fernández de Gamarra, Sacristán, Sara Cobo, Santiago, Emilio Bouza, Alonso, Ana Herranz, Paredes, Patricia Muñoz García de, Sáez, María Sanjurjo
Publikováno v:
In Journal of Infection and Public Health July 2023 16(7):1115-1122
Autor:
Bravo, Silvia Buendfa *, Pena, Eva Gonzalez Haba, Sanchez, Raquel Garcia, Duran, Paula Arrabal, Fresneda, Maria Norberta Sanchez, Saez, Maria Sanjurjo
Publikováno v:
In Farmacia Hospitalaria November-December 2015 39(6):333-337
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-de-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Beatriz Somoza-Fernandez, Paula Ruiz-Briones, Carlos Gonzalez, Ofelia Baniandres, Luis Menchén, Carmen Lobo-Rodríguez, Ana Herranz-Alonso, Maria Sanjurjo
BACKGROUND Pharmacotherapeutic management of immune-mediated inflammatory diseases (IMID) has become more complex due to the development of new treatments, such as biological therapies. Mobile health, especially apps, can provide IMID patients with g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8733e414896c6d820c9baafcdf1e8f0
https://doi.org/10.2196/preprints.36306
https://doi.org/10.2196/preprints.36306
Autor:
Paula Ruiz-Briones, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Juan Vicente-Valor, Rosa Alvarez, Cristina Villanueva-Bueno, Álvaro Narrillos-Moraza, Ana Herranz, Maria Sanjurjo
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211437
Introduction Osimertinib is a third-generation tyrosine kinase inhibitor (TKI) indicated for the treatment of epidermal growth factor receptor mutated non-small cell lung cancer (NSCLC). It has demonstrated better results concerning effectiveness tha
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-De-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Ana Herranz-Alonso, Maria Sanjurjo
Publikováno v:
Journal of medical Internet research. 24(3)
Background Immune-mediated inflammatory diseases (IMIDs) are systemic conditions associated with a high social and health impact. New treatments have changed the prognosis of IMIDs and have increased patient autonomy in disease management. Mobile app
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-De-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Ana Herranz-Alonso, Maria Sanjurjo
BACKGROUND Immune-mediated inflammatory diseases (IMIDs) are systemic conditions associated with a high social and health impact. New treatments have changed the prognosis of IMIDs and have increased patient autonomy in disease management. Mobile app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22ad58d9d2d1b7c9c62892db8039e599
https://doi.org/10.2196/preprints.31016
https://doi.org/10.2196/preprints.31016
Autor:
Ramón María Sanjurjo Zabala, Lucía Bermejo Telesca, Gema Ferrero Ballesteros, María Eugenia Schekaibán Sarquis, Andrés Sánchez Fernández, Miguel Ángel Flores Cordón, Amalia Fernández Moreno, Ximena Sapaj Araya, Alejandro Jiliberto Herrera
No me montes fiestas versa sobre el bienestar y la felicidad en el entorno corporativo. Su contenido está acompañado de las vivencias de sus coautores, de casos reales, herramientas de apoyo e ideas que ayudarán a las personas y empresas a impleme
Autor:
Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Almudena Ribed, Cristina Gonzalez-Anleo, Maite Martin-Conde, Rosa Romero-Jimenez, Irene Iglesias-Peinado, Ana Herranz-Alonso, Maria Sanjurjo-Saez
BACKGROUND Oral antineoplastic agents (OAAs) have revolutionized cancer management. However, they have been reported with adverse side effects and drug-drug interactions. Moreover, patient adherence to OAA treatment is critical. Mobile apps can enabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2361bdf73ffb96d21bad25fa1c08bd8
https://doi.org/10.2196/preprints.20480
https://doi.org/10.2196/preprints.20480